Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia

Haemophilia

Volumn 15, Issue 2, 2009, Pages 559-565

  Gerstner, G ^a   Damiano, M L ^a   Tom, A ^a   Worman, C ^b   Schultz, W ^b   Recht, Michael ^b,c   Stopeck, Alison T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Bone mineral density; Haemophilia; Osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JOINT MOBILITY; LABORATORY TEST; MASS SCREENING; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANGE OF MOTION; RISK FACTOR; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; AGED; BLOOD COAGULATION FACTORS; BONE DENSITY; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK FACTORS; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 63349110668     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01963.x     Document Type: Article

References (35)

1. NIH Publication. Osteoporosis Overview. Available at: http://www.niams.nih.gov/Health_Ifo/bone (last accessed on 20 November 2007).
2. Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002; 162: 2217-22.
3. Diamond TH, Thornley SW, Sekel R, Smerdely P. Hip fracture in elderly men: Prognostic factors and outcomes. Med J Aust 1997; 167: 412-5.
4. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-9.
5. NIH Publication. Osteoporosis in Men. Available at: http://www.niams.nih.gov/Health_Ifo/bone (last accessed on August 2008).
6. Diamond T, Campbell J, Bryant C, Lynch W. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: Longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer 1998; 83: 1561-6.
7. Lazo MG, Shirazi P, Sam M, Giobbie-Hurder A, Blacconiere MJ, Muppidi M. Osteoporosis and risk of fracture in men with spinal cord injury. Spinal Cord 2001; 39: 208-14.
8. Zehnder Y, Luthi M, Michel D et al. Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: A cross-sectional observational study in 100 paraplegic men. Osteoporos Int 2004; 15: 180-9.
9. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. AIDS 2006; 20: 2165-74.
10. Schiefke I, Fach A, Wiedmann M et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005; 11: 1843-7.
11. Katsarou O, Terpos E, Hatzismalis P et al. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophilia patients: correlations with severity of hemophilic arthropathy and HIV. Blood 2007; 110: 493a.
12. Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 2003; 921: 1-164.
13. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999; 281: 1505-11.
14. Ebeling PR. Clinical practice. Osteoporosis in men. N Engl J Med 2008; 358: 1474-82.
15. Liu H, Paige NM, Goldzweig CL et al. Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline. Ann Intern Med 2008; 148: 685-701.
16. Tlacuilo-Parra A, Morales-Zambrano R, Tostado-Rabago N, Esparza-Flores MA, Lopez-Guido B, Orozco-Alcala J. Inactivity is a risk factor for low bone mineral density among haemophilic children. Br J Haematol 2008; 140: 562-7.
17. Soucie JM, Cianfrini C, Janco RL et al. Joint range-of-motion limitations among young males with hemophilia: Prevalence and risk factors. Blood 2004; 103: 2467-73.
18. Nair AP, Jijina F, Ghosh K, Madkaikar M, Shrikhande M, Nema M. Osteoporosis in young haemophiliacs from western India. Am J Hematol 2007; 82: 453-7.
19. Barnes C, Wong P, Egan B et al. Reduced bone density among children with severe hemophilia. Pediatrics 2004; 114: E177-81.
20. Gallant JE, Staszewski S, Pozniak AL et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: A 3-year randomized trial. JAMA 2004; 292: 191-201.
21. Gibellini D, Borderi M, De Crignis E et al. RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. J Med Virol 2007; 79: 1446-54.
22. Leslie WD, Bernstein CN, Leboff MS. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003; 125: 941-66.
23. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998; 28: 695-9.
24. Moschen AR, Kaser A, Stadlmann S et al. The RANKL/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol 2005; 43: 973-83.
25. Gurevitch O, Slavin S. The hematological etiology of osteoporosis. Med Hypotheses 2006; 67: 729-35.
26. Glesby MJ. Bone disorders in human immunodeficiency virus infection. Clin Infect Dis 2003; 37 Suppl 2: S91-5.
27. Lee J, Kim JH, Kim K et al. Ribavirin enhances osteoclast formation through osteoblasts via up-regulation of TRANCE/RANKL. Mol Cell Biochem 2007; 296: 17-24.
28. Leslie WD, Adler RA, El-Hajj Fuleihan G et al. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: The 2005 ISCD Official Positions. J Clin Densitom 2006; 9: 22-30.
29. Ghosh K, Madkaikar M, Jijina F, Shetty S. Fractures of long bones in severe haemophilia. Haemophilia 2007; 13: 337-9.
30. Kovacs CS. Hemophilia, low bone mass, and osteopenia/osteoporosis. Transfus Apher Sci 2008; 38: 33-40.
31. Thornton J, Ashcroft D, O'Neill T et al. A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management. Health Technol Assess 2008; 12: 1-208.
32. Wallny TA, Scholz DT, Oldenburg J et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia 2007; 13: 79-84.
33. Gallacher SJ, Deighan C, Wallace AM et al. Association of severe haemophilia A with osteoporosis: A densitometric and biochemical study. Q J Med 1994; 87: 181-6.
34. Rodriguez-Merchan EC. Orthopaedic surgery of haemophilia in the 21st century: An overview. Haemophilia 2002; 8: 360-8.
35. McClung MR, Lewiecki EM, Cohen SB et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 2006; 354: 821-31.